6505--Bumetanide Tablets (VA-26-00011200)

The Department of Veterans Affairs National Acquisition Center is soliciting offers for Bumetanide Tablets in multiple strengths (0.5mg, 1mg, and 2mg) and package sizes (100 and 500 tablets per bottle) to supply the VA, Department of Defense, Indian Health Service, and Bureau of Prisons. The contract will establish a base year followed by four one-year option periods, with annual requirements estimated between 11,493 and 31,067 bottles per line item depending on strength and package configuration. Offerors must submit pricing for the base year and all four option years, include a 0.5% Cost Recovery Fee, and provide a unique 11-digit National Drug Code number along with FDA approval documentation. The solicitation requires compliance with specific packaging and bar coding requirements, and the contract is designated for small businesses with a size standard of 1,300 employees. The solicitation closing date is November 20, 2025, and interested parties should submit all required documentation by this deadline.

This procurement carries no set-aside designation beyond the small business requirement. McKesson Corporation is identified as the primary Government Prime Vendor contractor through which products will be distributed. While specific award values are not disclosed in the solicitation notice, the estimated annual quantities suggest a substantial contract value given the volume of tablets required across multiple line items and the five-year contract period. Distribution will occur through established prime vendor channels rather than direct government delivery. The location of performance and delivery requirements will be managed through the prime vendor distribution network serving VA medical facilities and partner agencies nationwide.